Showing results (1-10 of 47) with videos related to

Sort By:
Pageof 5
Oncology|April 28, 2026
Intratumoral Heamorrhage Induced by Atezolizumab plus Bevacizumab Combination Therapy in Patients with Hepatocellular CarcinomaTakashi Takeuchi, Hajime Yokota, Jun Koizumi, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|November 15, 2021
Changes in therapeutic options for hepatocellular carcinoma in AsiaSadahisa Ogasawara, Keisuke Koroki, Hiroaki Kanzaki, et al.
Cancer Medicine|February 27, 2025
Durvalumab Monotherapy in Complex Advanced Hepatocellular Carcinoma: A Real-World Study of Patients Ineligible for Combination ImmunotherapyChihiro Miwa, Sadahisa Ogasawara, Takuya Yonemoto, et al.
JHEP Reports : Innovation in Hepatology|October 1, 2025
Randomized phase II study comparing two doses of regorafenib in second-line treatment for advanced hepatocellular carcinomaKeisuke Koroki, Sadahisa Ogasawara, Sae Yumita, et al.
Plos One|January 27, 2022
Impact of acute decompensation on the prognosis of patients with hepatocellular carcinomaTakayuki Kondo, Keisuke Koroki, Hiroaki Kanzaki, et al.
American Journal of Physiology. Cell Physiology|September 9, 2024
Dual effects of targeting neuropilin-1 in lenvatinib-resistant hepatocellular carcinoma: inhibition of tumor growth and angiogenesisJunjie Ao, Na Qiang, Hiroaki Kanzaki, et al.
Scientific Reports|January 23, 2023
Phase II study comparing nasal pressure monitoring with capnography during invasive endoscopic procedures: a single-center, single-arm trialHiroki Nagashima, Rintaro Mikata, Shiroh Isono, et al.
Clinical and Molecular Hepatology|January 16, 2020
Switching to systemic therapy after locoregional treatment failure: Definition and best timingSadahisa Ogasawara, Yoshihiko Ooka, Keisuke Koroki, et al.
Diagnostics (Basel, Switzerland)|April 3, 2021
Percutaneous Two-Dimensional Shear Wave Elastography for Diagnosis of Pancreatic TumorYotaro Iino, Hitoshi Maruyama, Rintaro Mikata, et al.
International Journal of Medical Sciences|April 21, 2020
Long-term administration of Tolvaptan to patients with decompensated cirrhosisKengo Kanayama, Tetsuhiro Chiba, Kazufumi Kobayashi, et al.
Pageof 5